Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 65,000 | 34,365 | 2,871 | 2,764 | 11,476 |
| Gross Profit | 65,000 | 34,365 | 2,871 | 2,764 | 11,476 |
| Operating Expenses | 140,607 | 118,519 | 100,766 | 95,285 | 96,033 |
| Operating Income | -75,607 | -84,154 | -97,895 | -92,521 | -84,557 |
| Interest Expense | 81 | 61 | 92 | 98 | 108 |
| Other Income | 14,477 | 14,981 | 11,006 | 10,444 | 8,051 |
| Pre-tax Income | -61,211 | -69,234 | -86,981 | -82,175 | -76,614 |
| Net Income Continuous | -61,211 | -69,234 | -86,981 | -82,175 | -76,614 |
| Net Income | $-61,211 | $-69,234 | $-86,981 | $-82,175 | $-76,614 |
| EPS Basic Total Ops | -0.62 | -0.71 | -0.98 | -0.94 | -0.95 |
| EPS Basic Continuous Ops | -0.62 | -0.71 | -0.97 | -0.94 | -0.95 |
| EPS Diluted Total Ops | -0.62 | -0.71 | -0.98 | -0.94 | -0.95 |
| EPS Diluted Continuous Ops | -0.62 | -0.71 | -0.97 | -0.94 | -0.95 |
| EPS Diluted Before Non-Recurring Items | -0.62 | -0.71 | -0.97 | -0.90 | -0.95 |
| EBITDA(a) | $-75,904 | $-84,862 | $-97,908 | $-92,560 | $-84,594 |